NEW YORK (GenomeWeb News) – GATC Biotech has purchased a second Genome Sequencer FLX system from Roche’s 454 Life Sciences’ subsidiary, 454 announced today.
“Having two Genome Sequencer FLX Systems available enables us to execute very demanding sequencing projects on short notice and handle production peaks much better," Thomas Pohl, CTO of GATC, said in a statement. “For example, we are able to run one instrument with a paired-end application and the other one with single reads.”
Germany’s GATC, which provides sequencing services, purchased its first GS FLX system in March 2007.
Last summer, it also purchased and began offering sequencing services using Applied Biosystems’ SOLiD sequencer.